third-generation cephalosporin

powerful clinical secrets of cefixime What makes a third-generation cephalosporin antibiotic effective against certain Gram-negative pathogens while demonstrating limited activity against Staphylococcus aureus—and why does its oral bioavailability rarely exceed 50% regardless of dose escalation? This question lies at the heart of understanding cefixime’s clinical positioning. For decades, clinicians have relied on this orally administered…